Rakesh Jhunjhunwala’s favourite stock, which has already delivered magnificent gains of nearly 700% to his portfolio, is presently in the doldrums. Leading experts have opined that the stock is a “strong buy” now and that hefty gains can be reaped from it
Posts tagged Aurobindo Pharma
Rakesh Jhunjhunwala’s Fav Multibagger Stock Is A “Strong Buy” With Potential For Mega Gains: Experts
Demonetisation Is A “Huge Positive” & “Best Case Scenario” For Buying Stocks: Kenneth Andrade
Kenneth Andrade, the whiz-kid stock picker, has confidently asserted that NAMO’s surgical strike of demonetization is a “huge positive” and that it is giving us the rare chance to scoop us top-quality stocks at bargain-basement prices. He has also given a hint of the sort of stocks that we should focus on
Daljeet Kohli’s Fav “100-Bagger” Mid-Cap Pharma Stock Is “Ripe For Re-Rating” & Is Back In The Buy Zone
A mid-cap Pharma stock has become the favourite of several ace stock pickers because of it’s dominance in the market place, high RoEs, quality management and reasonable valuations. The stock is also proclaimed as a potential 100-bagger stock. Daljeet Kohli claims the stock is a good buy now because it is “ripe for re-rating“
Recent Comments